Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. The Compare-TAVI 2 Trial

NCT06470022 is registered in ClinicalTrials.gov with Christian Juhl Terkelsen as lead sponsor.

NCT NCT06470022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. The Compare-TAVI 2 Trial
Lead sponsor
Christian Juhl Terkelsen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 9, 2024
Completion date
November 20, 2036
Enrollment
1,370 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis